Recap: Beyond Air Q2 Earnings

Shares of Beyond Air XAIR fell 0.56% in after-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share increased 21.05% over the past year to ($0.30), which were in line with the estimate of ($0.30).

Revenue of $349,607 higher by 58167.83% year over year, which beat the estimate of $120,000.

Looking Ahead

Earnings guidance hasn't been issued by the company for now.

Beyond Air hasn't issued any revenue guidance for the time being.

How To Listen To The Conference Call

Date: Nov 11, 2020

Time: 04:30 PM

ET Webcast URL: http://public.viavid.com/player/index.php?id=141855

Recent Stock Performance

Company's 52-week high was at $12.50

Company's 52-week low was at $3.45

Price action over last quarter: Up 4.17%

Company Profile

Beyond Air Inc is a clinical-stage medical device and biopharmaceutical company which develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.